Evidence map›Paper›PMID 41503536›Full record

ArticleASM case reports2026

Fulminant and fatal

Georgi Lukose, Anna Mertelsmann, Rebecca M Marrero Rolon, David J Pisapia, Sanjay Patel, Christina Coyle, Lars F Westblade, Michael Satlin, Jamie Marino

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in ASM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Georgi LukoseDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.
Anna MertelsmannDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
Rebecca M Marrero RolonDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.
David J PisapiaDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.
Sanjay PatelDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.
Christina CoyleDepartment of Medicine, Albert Einstein College of Medicine, New York, New York, USA.
Lars F WestbladeDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.
Michael SatlinDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.ORCID https://orcid.org/0000-0003-4711-5334
Jamie MarinoDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.ORCID https://orcid.org/0009-0006-5604-7117

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Case Summary: A 61-year-old woman who had immigrated from El Salvador and was receiving obinutuzumab and zanubrutinib for follicular lymphoma in remission was admitted with persistent COVID-19 pneumonia. After multiple therapies for COVID-19, including more than 3 weeks of corticosteroid therapy for the possibility of organizing pneumonia, a peripheral blood smear identified Conclusion: Most cases of Chagas reactivation are described in people living with HIV-1 or transplant recipients. Rarely,

Indexed as

Chagas diseaselymphomareactivationTrypanosoma cruzi

Identifiers

PMID41503536
PMCPMC12772280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.